Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Prevention of Clostridium difficilespore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam

  • Julian R Garneau1,
  • Louis Valiquette1 and
  • Louis-Charles Fortier1Email author
BMC Infectious Diseases201414:29

DOI: 10.1186/1471-2334-14-29

Received: 9 August 2013

Accepted: 8 January 2014

Published: 15 January 2014

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
9 Aug 2013 Submitted Original manuscript
30 Sep 2013 Reviewed Reviewer Report - Aimee Shen
30 Sep 2013 Reviewed Reviewer Report - Meera Unnikrishnan
19 Nov 2013 Author responded Author comments - Louis-Charles Fortier
Resubmission - Version 2
19 Nov 2013 Submitted Manuscript version 2
9 Dec 2013 Reviewed Reviewer Report - Meera Unnikrishnan
18 Dec 2013 Reviewed Reviewer Report - Aimee Shen
28 Dec 2013 Author responded Author comments - Louis-Charles Fortier
Resubmission - Version 3
28 Dec 2013 Submitted Manuscript version 3
Publishing
8 Jan 2014 Editorially accepted
15 Jan 2014 Article published 10.1186/1471-2334-14-29

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Département de microbiologie et d’infectiologie, Faculté de médecine et des sciences de la santé, Université de Sherbrooke

Advertisement